Cephalalgia against the background of systemic mastocytosis: a clinical case
https://doi.org/10.20538/1682-0363-2021-2-239-244
Abstract
The article presents a clinical case of comorbid pathology – development of migraine against the background of systemic mastocytosis. The classification and clinical manifestations of systemic mastocytosis, a rare blood disease, are given.
This clinical case illustrates an example of excessive mast cell degranulation (with the release of proinflammatory and vasodilating agents as a result of mast cell pathology). In this regard, in addition to the pathogen-specific therapy for systemic mastocytosis (including prevention of mast cell degranulation), it seems important to describe the effectiveness and the possibility of prescribing preventive and emergency therapy for migraine against the background of the underlying hematological disease – systemic mastocytosis.
Treatment of cephalalgia in patients with mastocytosis is a complex clinical task, in the solution of which it is necessary to take into account serious limitations in prescription of acetylsalicylic acid and other non-steroidal anti-inflammatory drugs.
About the Authors
P. I. Kuznetsova
Research Сenter of Neurology
Russian Federation
Russian Federation
80, Volokolamskoe Highway, Moscow, 123367, Russian Federation
M. M. Tanashyan
Research Сenter of Neurology
Russian Federation
Russian Federation
80, Volokolamskoe Highway, Moscow, 123367, Russian Federation
A. L. Melikyan
National Research Center for Hematology
Russian Federation
Russian Federation
I. N. Subortseva
National Research Center for Hematology
Russian Federation
Russian Federation
4, New Zykovsky Av., Moscow, 125167, Russian Federation
A. A. Raskurazhev
Research Сenter of Neurology
Russian Federation
Russian Federation
80, Volokolamskoe Highway, Moscow, 123367, Russian Federation
References
1. Steiner T.J., Paemeleire K., Jensen R., Valade D., Savi L., Lainez M., Diener G., Martelletti P. European principles of management of common headache disorders in primary care. J. Headache Pain. 2007; 8 (1): S3–47. DOI: 10.1007/s10194-007-0366-y.
2. Осипова В.В., Филатова Е.Г., Артеменко А.Р.,. Лебедева Е.Р, Азимова Ю.Э., Латышева Н.В., Сергеев А.В., Амелин А.В., Корешкина М.И., Скоробогатых К.В., Екушева Е.В., Наприенко М.В., Исагулян Э.Д., Рачин А.П., Данилов Ал.Б., Курушина О.В., Парфенов В.А., Табеева Г.Р., Гехт А.Б., Яхно Н.Н. Диагностика и лечение мигрени: рекомендации российских экспертов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017; 117 (1): 28–42. DOI: 10.17116/jnevro20171171228-42.
3. Осипова В.В., Азимова Ю.Э., Табеева Г.Р., Тарасова С.А., Амелин А.В., Куцемелов И.В., Молдовану И.В., Одобеску С.С., Наумова Г.И. Диагностика головных болей в России и странах постсоветского пространства: состояние проблемы и пути ее решения. Анналы клинической и экспериментальной неврологии. 2012; 6 (2): 16–21.
4. Akin C., Metcalfe D.D. Systemic mastocytosis. Annu. Rev. Med. 2004; 55 (1): 419–432. DOI: 10.1146/annurev.med.55.091902.103822.
5. Recklinghausen F von. Über Eiter und Bindegewebskörperchen. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 1863; (28): 157–197.
6. Castells M., Austen K.F. Mastocytosis: mediator-related signs and symptoms. Int. Arch. Allergy Immunol. 2002; 127 (2): 147–152. DOI: 10.1159/000048188.
7. Valent P., Akin C., Metcalfe D.D. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017; 129 (11): 1420–1427. DOI: 10.1182/blood-2016-09-731893.
8. Scully R.E., Mark E.J., McNeely W.F., Ebeling S.H., Phillips L.D. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1997. A 74-year-old man with progressive cough, dyspnea, and pleural thickening. N. Engl. J. Med. 1997; 336 (26): 1895–1903. DOI: 10.1056/NEJM199706263362608.
9. Georgin-Lavialle S., Gaillard R., Moura D., Hermine O. Mastocytosis in adulthood and neuropsychiatric disorders. Transl. Res. 2016; 174: 77–85.e1. DOI: 10.1016/j.trsl.2016.03.013.
10. Hermine O., Lortholary O., Leventhal P.S., Catteau A., Soppelsa F., Baude C., Lortholary O., Leventhal P.S., Catteau A., Soppelsa F., Cohen-Akenine A., Palmérini F., Hanssens K., Yang Y., Sobol H., Fraytag S., Ghez D. et al. Case-control cohort study of patients’ perceptions of disability in mastocytosis. PLoS One. 2008; 3 (5): e2266. DOI: 10.1371/journal.pone.0002266.
11. Theoharides T.C., Donelan J., Kandere-Grzybowska K., Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res. Rev. 2005; 49 (1): 65–76. DOI: 10.1016/j.brainresrev.2004.11.006.
12. Spierings E.L.H. Pathogenesis of the migraine attack. Clin. J. Pain. 2003; 19 (4): 255–262. DOI: 10.1097/00002508-200307000-00009.
13. The International сlassification of headache disorders; 2nd ed. Cephalalgia. 2004; 24 (1): 9–160. DOI: 10.1111/j.1468-2982.2003.00824.x.
14. Smith J.H., Butterfield J.H., Cutrer F.M. Primary headache syndromes in systemic mastocytosis. Cephalalgia. 2011; 31 (15): 1522–1531. DOI: 10.1177/0333102411421683.
15. Melikian A.L., Subortseva I.N., Goriacheva S.R., Kolosheinova T.I., Vakhrusheva M.V., Kovrigina A.M. et al. Mastocytosis. Review of the literature and description of clinical cases. Ter. Arkh. 2014; 86 (12): 127–134. DOI: 10.17116/terarkh20148612127-134.
Review
For citations:
Kuznetsova P.I., Tanashyan M.M., Melikyan A.L., Subortseva I.N., Raskurazhev A.A. Cephalalgia against the background of systemic mastocytosis: a clinical case. Bulletin of Siberian Medicine. 2021;20(2):239-244. https://doi.org/10.20538/1682-0363-2021-2-239-244
Views:
978
Email this article 